Voyager Therapeutics Up 9%; Restructures Relationship with Sanofi Genzyme

Date : 06/18/2019 @ 1:17AM
Source : Dow Jones News
Stock : Sanofi (SAN)
Quote : 82.68  0.23 (0.28%) @ 11:40PM
Sanofi share price Chart

Voyager Therapeutics Up 9%; Restructures Relationship with Sanofi Genzyme

Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart

6 Months : From Apr 2019 to Oct 2019

Click Here for more Voyager Therapeutics Charts.

By Michael Dabaie


Voyager Therapeutics Inc. (VYGR) shares were up 9% to $26.52 in midday trading Monday.

The clinical-stage gene therapy company said earlier it restructured its gene therapy relationship with Sanofi Genzyme.

Voyager said it is gaining world-wide rights to the VY-HTT01 Huntington's disease program and ex-U.S. rights to the VY-FXN01 Friedreich's ataxia program. Voyager is, in turn, transferring the ex-U.S. rights to VY-FXN01 to Neurocrine Biosciences Inc. (NBIX) under the terms of a collaboration agreement.

Neurocrine shares were up 2.3% to $85.82.

To focus resources on the now wholly-owned Huntington's disease program, Voyager said it would seek a partner to advance its preclinical program for SOD1 amyotrophic lateral sclerosis. Voyager said it no longer expects to file an investigational new drug application with the U.S. Food and Drug Administration for its VY-SOD102 in 2019.


Write to Michael Dabaie at


(END) Dow Jones Newswires

June 17, 2019 13:02 ET (17:02 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

Finance Manila is owned and operated by ADVFN PLC.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:fm D:20191016 21:02:00